Labeling Solutions Brochure
This brochure gives an overview of common pharmaceutical and healthcare applications and the UPM Raflatac label solutions that meet these various needs. Every pharmaceutical packaging and labeling solution must comply with strict industry regulations. UPM Raflatac pharmaceutical label materials meet or exceed the following regulatory and safety requirements:
- EMA (European Medicines Agency)/CVMP/205/04 Guideline on plastic immediate packaging materials 19 May 2005
- FDA (Food and Drug Administration, USA) Guidance on Container Closure Systems for Packaging Human Drugs and Biologics (1999)
- Compliance with 1907/2006/EC (REACH)
- European food contact regulations; Food Framework Regulation 1935/2004,plastics regulated by EU 10/2011
- FDA food contact compliance: FDA 21 CFR 175.105 and 175.125 for adhesives; FDA 21 CFR 176.170 and 176.180 for papers
- Falsified Medicines Directive (2011/62/EU
UPM Raflatac
-
US
-
2018On CPHI since
-
1Certificates
-
1000 - 4999Employees
Other Content from UPM Raflatac ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance